# Health2Sync

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/health2sync

- Industry: Healthcare IT
- Headquarters: Taipei, Taiwan - China
- Website: www.health2sync.com
- Total disclosed funding: $30M
- Latest round: Series C (Mar 5, 2025)
- Investors on record: 12

## About

Established in 2013 and based in Taipei, China, Health2Sync operates as a health management platform dedicated to providing health management application. It has an office in Tokyo, Japan. The company acquired certifications such as ISO27001 and ISO27017.In March 2025, Health2Sync raised USD 20 million in series C funding led by Taiwania Capital, with participation from Wistron Corporation, BE Health Ventures, Cathay Venture, Pegatron, ABIES Capital, and other unspecified investors. The company mainly provides health management application. It provides anti-sugar App and cloud care platform. The anti-sugar App allows patients to track vitals such as blood glucose levels, blood pressure, and weight, along with factors that influence those readings such as diet, exercise and medication as well as offers analysis and reminders services, enabling diabetics to better self-manage their blood glucose and allow family and health professionals to provide care where necessary. The company generates revenue by providing health management application anti-sugar App.

The company will use the March 2025 funding to expand into new markets, support its growth, and prepare for a public listing in Taiwan.

## Funding rounds

- Series C, Mar 5, 2025, $20M — Pegatron, Taiwania Capital, Cathay Venture, BE Health Ventures, Wistron Corporation, ABIES Capital
- Series B, Dec 6, 2017, $6M — WI Harper Group, Alibaba Group, Sompo Himawari Life Insurance Inc.
- Series A, Aug 30, 2016, $3M — WI Harper Group, SparkLabs Global Ventures, Cherubic Ventures, iSeed Ventures
- Seed, Jun 1, 2014, $1.2M — Cherubic Ventures

## Investors

- Cherubic Ventures (https://capitalatlas.ai/funds/cherubic-ventures) — Seed, Series A
- WI Harper Group (https://capitalatlas.ai/funds/wi-harper-group) — Series A, Series B
- SparkLabs Global Ventures (https://capitalatlas.ai/funds/sparklabs-global-ventures) — Series A
- iSeed Ventures (https://capitalatlas.ai/funds/iseed-ventures) — Series A
- Alibaba Group — Series B
- Sompo Himawari Life Insurance Inc. — Series B
- Pegatron — Series C
- Taiwania Capital (https://capitalatlas.ai/funds/taiwania-capital) — Series C
- Cathay Venture — Series C
- BE Health Ventures (https://capitalatlas.ai/funds/be-health-ventures) — Series C
- Wistron Corporation — Series C
- ABIES Capital (https://capitalatlas.ai/funds/abies-capital) — Series C